1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with cycloheximide in 42 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (cycloheximide) | Trials (cycloheximide) | Recent Studies (post-2010) (cycloheximide) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 19,109 | 6 | 861 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | cycloheximide (IC50) |
---|---|---|---|
COUP transcription factor 2 isoform a | Homo sapiens (human) | 1.315 | |
Glucose transporter | Leishmania mexicana | 0.242 | |
Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.31 | |
Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | 0.228 | |
Eukaryotic initiation factor 4A-I | Homo sapiens (human) | 0.139 | |
Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 3.6 | |
Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 0.036 | |
Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 0.036 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (14.29) | 18.7374 |
1990's | 35 (83.33) | 18.2507 |
2000's | 1 (2.38) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chao, W; Liu, H; Olson, MS | 1 |
Jacobson, DP; O'Flaherty, JT; Redman, JF | 1 |
Fernandez-Gallardo, S; Guntaka, RV; Kandala, JC; Lim, RW; Shukla, SD; Tripathi, YB | 1 |
Bergström, M; Carlsson, J; Gáti, I; Långström, B; Muhr, C | 1 |
Hiramoto, M; Imaizumi, T; Kawamura, Y; Satoh, K; Takamatsu, M; Takamatsu, S; Yoshida, H | 1 |
Ahnfelt-Rønne, I; Kirstein, D; Larsen, CG; Skak-Nielsen, T; Thestrup-Pedersen, K; Thomsen, HK; Thomsen, MK | 1 |
Asmis, R; Dennis, EA; Glaser, KB | 1 |
Guntaka, RV; Kandala, JC; Lim, RW; Shukla, SD; Tripathi, YB | 1 |
Valone, FH | 1 |
Cordeiro, RS; e Silva, PM; Faria Neto, HC; Martins, MA; Vargaftig, BB | 1 |
Cordeiro, RS; e Silva, PM; Martins, MA; Pasquale, CP; Vargaftig, BB | 1 |
Dahinden, CA; de Weck, AL; Wirthmueller, U | 1 |
Frick, KK; Scher, CD; Womer, RB | 1 |
Ewenstein, BM; Pober, JS; Schafer, AI; Zavoico, GB | 1 |
Aglietta, M; Breviario, F; Bussolino, F; Dejana, E; Mantovani, A; Tetta, C | 1 |
Ho, YS; Lee, WM; Snyderman, R | 1 |
Bochner, BS; Brown, KE; Peachell, PT; Schleimer, RP | 1 |
Baglioni, C; Bussolino, F; Camussi, G | 1 |
Biancone, L; Camussi, G; Duc, TM; Montrucchio, G; Ruikun, C; Silvestro, L; Sommer, F | 1 |
Inoue, H; Koshihara, Y; Nagata, N | 1 |
Leduc, D; Pretolani, M; Vargaftig, BB; Zuany-Amorim, C | 1 |
Hidaka, T; Ishizuka, T; Kawaguchi, Y; Kawakami, M; Matsuki, Y; Nakamura, H; Suzuki, K | 1 |
Shearer, WT; Smith, CS | 1 |
Hartnell, A; Kay, AB; Robinson, DS; Wardlaw, AJ | 1 |
Parent, JL; Stankova, J | 1 |
Bozza, PT; Castro-Faria-Neto, HC; Cordeiro, RS; e Silva, PM; Larangeira, AP; Martins, MA; Perales, JE | 1 |
Bazan, HE; Bazan, NG; Tao, Y | 1 |
Alami, N; de Brum-Fernandes, AJ; Müller, E; Rola-Pleszczynski, M; Thivierge, M | 1 |
Fujii, E; Irie, K; Muraki, T; Ogawa, A; Ohba, K | 1 |
Howard, KM; Mustafa, SB; Olson, MS | 1 |
Misra, UK; Pizzo, SV | 1 |
Hellewell, PG; Macari, DM; Teixeira, MM | 1 |
Fang, GD; Guerrant, RL; Marcinkiewicz, M; Sarosiek, J; Thielman, NM | 1 |
Bustos, C; Egido, J; Gómez-Garre, D; Largo, R; Ruiz-Ortega, M | 1 |
Chang, H; Gonzalez-Crussi, F; Hsueh, W; Qu, XW; Remick, DG; Tan, XD; Wang, H | 1 |
Baydoun, AR; Cannon, TR; Mann, GE | 1 |
Izumi, T; Koyama, S; Kubo, K; Masubuchi, T; Nagai, S; Nomura, H; Sato, E; Takamizawa, A | 1 |
Izumi, T; Koyama, S; Kubo, K; Miura, M; Nagai, S; Nomura, H; Sato, E; Yamashita, T | 2 |
Bastien, Y; Mazer, B; Noya, F; Toledano, BJ | 1 |
Delong, P; Hubbard, CL; Huggins, E; McCall, C; O'Sullivan, MG | 1 |
Cui, XF; Hatakeyama, M; Imaizumi, T; Kimura, D; Kumagai, M; Matsumiya, T; Sakaki, H; Sato, Y; Satoh, K; Shibata, T; Tamo, W; Tanji, K; Yoshida, H | 1 |
42 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cycloheximide
Article | Year |
---|---|
Regulation of the surface expression of the platelet-activating factor receptor in IC-21 peritoneal macrophages. Effects of lipopolysaccharide.
Topics: Acetates; Animals; Bucladesine; Calcium; Cell Line; Colforsin; Cycloheximide; Dactinomycin; Kinetics; Lipopolysaccharides; Macrophages; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandin D2; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1992 |
Regulation of platelet-activating-factor receptors and the desensitization response in polymorphonuclear neutrophils.
Topics: Calcium; Cycloheximide; Dactinomycin; Humans; Kinetics; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Serum Albumin, Bovine | 1992 |
Involvement of tyrosine kinase and protein kinase C in platelet-activating-factor-induced c-fos gene expression in A-431 cells.
Topics: Alkaloids; Blotting, Northern; Cinnamates; Colforsin; Cycloheximide; Gene Expression; Genes, fos; Genistein; Humans; Isoflavones; Platelet Activating Factor; Protein Kinase C; Protein-Tyrosine Kinases; RNA; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1992 |
Application of (methyl-11C)-methionine in the multicellular spheroid system.
Topics: Benzeneacetamides; Benzoquinones; Carbon Radioisotopes; Cell Aggregation; Cell Line; Cycloheximide; Humans; Hydroxamic Acids; In Vitro Techniques; Lipoxygenase Inhibitors; Methionine; Platelet Activating Factor; Pyridinium Compounds; Tumor Cells, Cultured | 1991 |
Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetophenones; Carcinoma, Hepatocellular; Cell Survival; Chromatography, Gel; Cycloheximide; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Humans; Hydrolysis; Isoflurophate; L-Lactate Dehydrogenase; Liver Neoplasms; Methionine; Phospholipases A; Phospholipases A2; Phospholipids; Platelet Activating Factor; Precipitin Tests; Tumor Cells, Cultured | 1991 |
Recombinant human interleukin-8 is a potent activator of canine neutrophil aggregation, migration, and leukotriene B4 biosynthesis.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cell Aggregation; Chemotaxis, Leukocyte; Cycloheximide; Dogs; Humans; Injections, Intradermal; Interleukin-1; Interleukin-8; Kinetics; Leukotriene B4; Neutrophils; Platelet Activating Factor; Recombinant Proteins; Skin | 1991 |
PAF receptor mediated PGE2 production in LPS primed P388D1 macrophage-like cells.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cycloheximide; Cyclooxygenase Inhibitors; Dactinomycin; Dinoprostone; Enzyme Activation; Gene Expression Regulation, Neoplastic; Genistein; Isoflavones; Lipopolysaccharides; Macrophages; Mice; Phospholipases A; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandin-Endoperoxide Synthases; Protein-Tyrosine Kinases; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Signal Transduction; Tumor Cells, Cultured | 1991 |
Platelet activating factor induces expression of early response genes c-fos and TIS-1 in human epidermoid carcinoma A-431 cells.
Topics: Cycloheximide; Gene Expression Regulation, Neoplastic; Genes, fos; Humans; Kinetics; Platelet Activating Factor; Pyridinium Compounds; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1991 |
Synthesis of platelet-activating factor by human monocytes stimulated by platelet-activating factor.
Topics: Cells, Cultured; Cycloheximide; Feedback; Humans; In Vitro Techniques; Monocytes; Platelet Activating Factor; Time Factors | 1991 |
Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats.
Topics: Animals; Chemotactic Factors, Eosinophil; Chemotaxis, Leukocyte; Cycloheximide; Dactinomycin; Dexamethasone; Diterpenes; Drug Stability; Eosinophils; Ginkgolides; Lactones; Male; Platelet Activating Factor; Pleura; Rats; Rats, Inbred Strains; Temperature | 1991 |
Eosinophil accumulation in the rat pleural cavity after mast cell stimulation with compound 48/80 involves protein synthesis and is selectively suppressed by dexamethasone.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Azepines; Cycloheximide; Dexamethasone; Eosinophils; Female; Leukocyte Count; Male; Mast Cells; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Pleura; Protein Biosynthesis; Rats; Rats, Inbred Strains; Triazoles | 1990 |
Studies on the mechanism of platelet-activating factor production in GM-CSF primed neutrophils: involvement of protein synthesis and phospholipase A2 activation.
Topics: Arachidonate 5-Lipoxygenase; Arachidonate Lipoxygenases; Colony-Stimulating Factors; Cycloheximide; Dactinomycin; Enzyme Activation; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Humans; Leucine; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipases; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Uridine | 1990 |
Platelet-derived growth factor-induced c-myc RNA expression. Analysis of an inducible pathway independent of protein kinase C.
Topics: Calcimycin; Cycloheximide; Egtazic Acid; Ethers; Gene Expression Regulation; Humans; Ionomycin; Oncogenes; Osteosarcoma; Platelet Activating Factor; Protein Kinase C; RNA; Tumor Cells, Cultured | 1988 |
IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis.
Topics: Arachidonic Acid; Arachidonic Acids; Cells, Cultured; Chromatography, Thin Layer; Cycloheximide; Drug Synergism; Endothelium, Vascular; Epoprostenol; Histamine; Humans; Interleukin-1; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Thrombin; von Willebrand Factor | 1989 |
Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells.
Topics: Acetyl Coenzyme A; Acetyl-CoA C-Acetyltransferase; Aspirin; Cells, Cultured; Chromatography, High Pressure Liquid; Cycloheximide; Dose-Response Relationship, Drug; Endothelium; Hirudins; Humans; Interleukin-1; Lipopolysaccharides; Platelet Activating Factor | 1986 |
Chemoattractant-induced activation of c-fos gene expression in human monocytes.
Topics: beta 2-Microglobulin; Cycloheximide; Dactinomycin; Gene Expression Regulation; GTP-Binding Proteins; Humans; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Pertussis Toxin; Platelet Activating Factor; Protein Biosynthesis; Protein Kinase C; Proto-Oncogenes; Tetradecanoylphorbol Acetate; Transcription, Genetic; Transcriptional Activation; Virulence Factors, Bordetella | 1987 |
Adherence of human basophils to cultured umbilical vein endothelial cells.
Topics: Basophils; Calcimycin; Cations, Divalent; Cell Adhesion; Cell Line; Complement C5; Complement C5a; Cycloheximide; Dactinomycin; Endothelium, Vascular; Glucocorticoids; Humans; Interleukin-1; Kinetics; Lipopolysaccharides; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Temperature; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Umbilical Veins | 1988 |
Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha.
Topics: Acetyltransferases; Cells, Cultured; Chromatography, Thin Layer; Cycloheximide; Dactinomycin; Drug Interactions; Endothelium, Vascular; Enzyme Induction; Humans; Interleukin-1; Kinetics; Platelet Activating Factor; Recombinant Proteins; Tumor Necrosis Factor-alpha; Umbilical Veins | 1988 |
Platelet-activating factor-induced endothelial cell expression of adhesion molecules and modulation of surface glycocalyx, evaluated by electron spectroscopy chemical analysis.
Topics: Antibodies, Monoclonal; Azepines; CD18 Antigens; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Cycloheximide; Electron Probe Microanalysis; Endothelium, Vascular; Fluorescent Antibody Technique; Gene Expression Regulation; Glycoproteins; Humans; Neutrophils; P-Selectin; Platelet Activating Factor; Platelet Membrane Glycoproteins; Polysaccharides; Proteoglycans; Triazoles; Umbilical Veins | 1994 |
Inhibition by actinomycin D of neurogenic mouse ear oedema.
Topics: Animals; Bradykinin; Calcimycin; Calcitonin Gene-Related Peptide; Capsaicin; Cycloheximide; Dactinomycin; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Ear Diseases; Edema; Histamine; Injections, Intravenous; Leukotriene C4; Male; Mast Cells; Mice; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Rats; Rats, Wistar; Serotonin; Substance P; Tachykinins; Vasoactive Intestinal Peptide | 1995 |
Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.
Topics: Animals; Benzeneacetamides; Cetirizine; Cycloheximide; Dexamethasone; Eosinophils; Histamine Release; Hydroxamic Acids; Indomethacin; Kinetics; Leukocyte Count; Leukotriene B4; Leukotriene C4; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Peritoneal Cavity; Peritonitis; Platelet Activating Factor; T-Lymphocytes; Tacrolimus; Terfenadine; Thiazoles; Zymosan | 1993 |
DP-1904, a specific inhibitor of thromboxane A2 synthesizing enzyme, suppresses ICAM-1 expression by stimulated vascular endothelial cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Cell Division; Cells, Cultured; Cycloheximide; Endothelium, Vascular; Epoprostenol; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Humans; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-1; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Recombinant Proteins; Tetrahydronaphthalenes; Thrombin; Thromboxane A2; Thromboxane-A Synthase; Tumor Necrosis Factor-alpha; Umbilical Veins | 1994 |
Activation of NF-kappa B and immunoglobulin expression in response to platelet-activating factor in a human B cell line.
Topics: B-Lymphocytes; Base Sequence; Cell Nucleus; Cycloheximide; Gene Expression Regulation; Genes, Immunoglobulin; Humans; Immunoglobulin kappa-Chains; Molecular Sequence Data; NF-kappa B; Platelet Activating Factor; Protein Binding; Protein Precursors; RNA, Messenger; Tumor Cells, Cultured | 1994 |
CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines.
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Asthma; Bronchoalveolar Lavage Fluid; Cells, Cultured; Cycloheximide; Cytokines; Dexamethasone; Eosinophils; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Lectins, C-Type; Platelet Activating Factor | 1993 |
Transforming growth factor-beta up-regulates the gene expression of the human platelet-activating factor receptor in monocytic and B cell lines.
Topics: Azepines; B-Lymphocytes; Calcium; Cell Line; Cycloheximide; Dactinomycin; Gene Expression; Humans; Ionomycin; Kinetics; Monocytes; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Messenger; Time Factors; Transcription, Genetic; Transforming Growth Factor beta; Triazoles; Tumor Cells, Cultured; Up-Regulation | 1993 |
Pharmacological modulation of lipopolysaccharide-induced pleural eosinophilia in the rat; a role for a newly generated protein.
Topics: Animals; Cycloheximide; Dexamethasone; Eosinophils; Escherichia coli; Female; Hot Temperature; Hydrolysis; Leukocyte Count; Lipopolysaccharides; Lipoxygenase Inhibitors; Male; Molecular Weight; Platelet Activating Factor; Pleura; Protein Biosynthesis; Proteins; Rats; Rats, Wistar; Trypsin; Ultrafiltration | 1993 |
Platelet-activating factor induces collagenase expression in corneal epithelial cells.
Topics: Animals; Azepines; Base Sequence; Blotting, Northern; Collagenases; Cornea; Cycloheximide; Epithelium; Gene Expression; Genes, fos; Genes, jun; Kinetics; Molecular Sequence Data; Oligodeoxyribonucleotides; Organ Culture Techniques; Platelet Activating Factor; Rabbits; RNA, Messenger; Tetrazoles; Thienopyridines; Triazoles | 1993 |
Transcriptional modulation of platelet-activating factor receptor gene expression by cyclic AMP.
Topics: Animals; Azepines; Bucladesine; Calcium; Cell Membrane; Cells, Cultured; Cricetinae; Cyclic AMP; Cycloheximide; Dinoprostone; Flow Cytometry; Gene Expression Regulation; Humans; Kinetics; Monocytes; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Messenger; Transcription, Genetic; Triazoles | 1993 |
Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin.
Topics: Animals; Capillary Permeability; Cycloheximide; Drug Synergism; Enzyme Inhibitors; Lipopolysaccharides; Male; Mice; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Prostaglandins | 1996 |
Platelet-activating factor augments lipopolysaccharide-induced nitric oxide formation by rat Kupffer cells.
Topics: Animals; Arginine; Biological Transport, Active; Cells, Cultured; Cyclic GMP; Cycloheximide; Dactinomycin; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Kinetics; Kupffer Cells; Lipopolysaccharides; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor; Protein Synthesis Inhibitors; Rats; RNA, Messenger; Shock, Septic | 1996 |
Ligation of the alpha 2-macroglobulin signaling receptor on macrophages induces synthesis of platelet activating factor.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Alkaloids; alpha-Macroglobulins; Animals; Cells, Cultured; Choline; Cycloheximide; Low Density Lipoprotein Receptor-Related Protein-1; Macrophages; Mice; Mice, Inbred C57BL; Pertussis Toxin; Phospholipases A; Platelet Activating Factor; Protein Kinase C; Receptors, Immunologic; Specific Pathogen-Free Organisms; Staurosporine; Virulence Factors, Bordetella | 1996 |
Priming of eosinophil recruitment in vivo by LPS pretreatment.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Azepines; CD18 Antigens; Chemotactic Factors, Eosinophil; Chemotaxis, Leukocyte; Complement C5a, des-Arginine; Cycloheximide; Drug Synergism; Edema; Eosinophilia; Eosinophils; Female; Guinea Pigs; Immunoglobulin G; Interleukin 1 Receptor Antagonist Protein; Leukocyte Count; Leukotriene B4; Lipopolysaccharides; Lipoxygenase Inhibitors; Neutrophils; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Protein Synthesis Inhibitors; Pyrans; Quinolones; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; Sialoglycoproteins; Skin; Triazoles; Zymosan | 1996 |
Role of platelet-activating factor in Chinese hamster ovary cell responses to cholera toxin.
Topics: Alprostadil; Animals; Bucladesine; Cell Size; CHO Cells; Cholera Toxin; Cricetinae; Cyclic AMP; Cycloheximide; Dactinomycin; Dinoprostone; Diterpenes; Ginkgolides; Humans; Lactones; Phospholipases A; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Synthesis Inhibitors; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles | 1997 |
Platelet-activating factor stimulates gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta.
Topics: Animals; Antibodies; Cells, Cultured; Collagen; Cycloheximide; Extracellular Matrix Proteins; Fibronectins; Gene Expression; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Humans; Platelet Activating Factor; Protein Kinase C; Protein Synthesis Inhibitors; Rats; RNA, Messenger; Transforming Growth Factor beta | 1997 |
Platelet-activating factor (PAF) up-regulates plasma and tissue PAF-acetylhydrolase activity in the rat: effect of cycloheximide.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Cycloheximide; Intestinal Mucosa; Intestines; Male; Necrosis; Phospholipases A; Platelet Activating Factor; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Up-Regulation | 1997 |
Mechanisms of acute vasodilator response to bacterial lipopolysaccharide in the rat coronary microcirculation.
Topics: Animals; Annexin A1; Bradykinin; Bradykinin Receptor Antagonists; Coronary Vessels; Cycloheximide; Dexamethasone; Enzyme Inhibitors; In Vitro Techniques; Lipopolysaccharides; Lipoxygenase; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Vasodilation | 1998 |
Human lung fibroblasts release chemokinetic activity for monocytes constitutively.
Topics: Adult; Antibodies; Cell Line; Chemokine CCL2; Chemokine CCL5; Chemotaxis, Leukocyte; Cycloheximide; Diethylcarbamazine; Fibroblasts; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Kinetics; Lipoxygenase Inhibitors; Lung; Masoprocol; Monocytes; Platelet Activating Factor; Receptors, Leukotriene B4; T-Lymphocytes; Time Factors; Transforming Growth Factor beta; Trypsin | 1998 |
Bradykinin stimulates type II alveolar cells to release neutrophil and monocyte chemotactic activity and inflammatory cytokines.
Topics: Antibodies; Bradykinin; Bradykinin Receptor Antagonists; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Chemotactic Factors; Culture Media, Conditioned; Cycloheximide; Granulocyte Colony-Stimulating Factor; Humans; Interleukin-6; Interleukin-8; Isoquinolines; Leukotriene B4; Lipoxygenase Inhibitors; Phenylpropionates; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pulmonary Alveoli; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Leukotriene B4; Tetrahydroisoquinolines; Transforming Growth Factor beta | 1998 |
Characterization of B lymphocytes rescued from apoptosis by platelet-activating factor.
Topics: Apoptosis; B-Lymphocytes; Cycloheximide; Humans; Immunoglobulin M; Integrin alpha4beta1; Integrins; Platelet Activating Factor; Protein Biosynthesis; Receptors, Antigen, B-Cell; Receptors, Lymphocyte Homing | 1999 |
Bacterial lipopolysaccharide induction of the prostaglandin G/H synthase 2 gene causes thromboxane-dependent pulmonary hypertension in rabbits.
Topics: Animals; Arachidonic Acid; Cycloheximide; Cyclooxygenase 1; Cyclooxygenase 2; Dactinomycin; Drug Interactions; Enzyme Induction; Female; Hypertension, Pulmonary; In Vitro Techniques; Isoenzymes; Lipopolysaccharides; Perfusion; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rabbits; Thromboxanes | 1999 |
The potential of various lipopolysaccharides to release monocyte chemotactic activity from lung epithelial cells and fibroblasts.
Topics: Cells, Cultured; Chemokine CCL2; Chemotaxis, Leukocyte; Cycloheximide; Epithelial Cells; Escherichia coli; Fibroblasts; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukotriene B4; Lipopolysaccharides; Lipoxygenase Inhibitors; Lung; Monocytes; Platelet Activating Factor; Platelet Membrane Glycoproteins; Polymyxin B; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1999 |
Platelet-activating factor enhances the expression of vascular endothelial growth factor in normal human astrocytes.
Topics: Anti-Inflammatory Agents; Astrocytes; Brain; Cells, Cultured; Cycloheximide; Deferoxamine; Dexamethasone; Dose-Response Relationship, Drug; Endothelial Growth Factors; Gene Expression Regulation; Humans; Hypoxia, Brain; Iron Chelating Agents; Lymphokines; Nerve Degeneration; Neurons; Platelet Activating Factor; Protein Synthesis Inhibitors; RNA, Messenger; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |